Inflammx Therapeutics is a biotechnology startup company.
Inflammx Therapeutics has raised $5.8M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Inflammx Therapeutics's investors include Uniservices.
Inflammx Therapeutics is headquartered in Tampa, United States.
Inflammx Therapeutics is a biotechnology startup company.
Inflammx Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inflammx Therapeutics — Funding & Investors." VCBacked, January 10, 2025, https://www.vcbacked.co/company/inflammx-therapeutics. Accessed October 31, 2026.
VCBacked. (2025). Inflammx Therapeutics — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/inflammx-therapeutics
{{cite web |title=Inflammx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/inflammx-therapeutics |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated